ethyl 4-(2,5-dimethylphenyl)-2-hydroxy-4-oxobut-2-enoate, 95%, 100mg

2-(2-Ethylphenyl)acetonitrile, 97%, 250mg

DMT-dG(ib) Phosphoramidite, 5g

2-bromo-5,6-dichloro-1H-1,3-benzodiazole, 100mg

2-Amino-1,5-dihydropteridin-4-ol, 95.0%, 1g

8-Bromo-1-naphthoic acid, 95.0%, 1g

(2R,3S,4R)-2,3,4,5-tetrahydroxypentanoic acid, 98%, 100mg

2,3,5,6-Tetrafluoro-4-(trifluoromethyl)benzenethiol>97.0%(GC)(T)1g

6-Chloro-9-ethyl-8-iodo-9H-purine, 97%, 250mg

(1R,3S)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate compound with (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate, 98%, 250mg

(1-(5-Bromopyridin-2-yl)cyclopropyl)methanol, 95+%, 5g

6-Bromoimidazo[1,2-a]pyrimidine, 95.0%, 25g

Methyl 1H-benzo[d]imidazole-4-carboxylate, 95.0%, 5g